DCSIMG
Abbott UK
21 May 2010 Abbott recognised once again as one of the UK's Best Workplaces
19 May 2010 Adalimumab Recommended by NICE for Crohn's Disease Sufferers for the First Time in the UK
16 February 2010 Abbott Completes Acquisition of Solvay Pharmaceuticals
10 February 2010 New Heat-Stable NorvirŽ (ritonavir) Tablet Approved in Europe
21 January 2010 Abbott to Suspend Marketing of Obesity Medicine Sibutramine in European Union Countries
30 September 2009 Abbott Cuts Use of Oil and Coal by 35 Percent
25 September 2009 Abbott Receives European Approval for Once-Daily Dosing of KaletraŽ (lopinavir/ritonavir) Tablet
16 September 2009 Abbott expands use of sustainable packaging as part of global environmental efforts
16 July 2009 New research shows the impact of excess weight on self esteem
29 June 2009 Olympic Gold Medallist helps Abbott employees fit fitness into their work lives
22 May 2009 Abbott recognised as one of the UK's Best Work places by the Great Place to Work Institute
11 December 2008 Abbott named one of Britain's Most Admired Healthcare Companies by Management Today
26 August 2008 Clinicians Visit from Africa and Asia to Find Out About UK HIV Practices
25 June 2008 NICE Recommends Abbott's Adalimumab (HUMIRAŽ) for the Treatment of Chronic Plaque Psoriasis
28 May 2008 NICE Recommends Abbott's Adalimumab (HUMIRAŽ) for the Treatment of Severe Active Ankylosing Spondylitis
11 March 2008 Abbott UK Rated 'Outstanding' Place to Work
24 August 2007 Abbott Staff Volunteer Team Restores Redlees Play Area
7 July 2007Abbott Retains Investors in People Standard for Eleventh Year Running
2 November 2006Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-infected Children in Malawi

For all media enquiries, please contact the Communications department on 01628 644582 or email ukcommunications@abbott.com.